Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ASP Isotopes Inc ASPI

Healthcare Biotechnology
ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.


NDAQ:ASPI - Post by User

ASP Isotopes Inc
<< Previous
 Bullboard Posts
User Avatar Image
(291)
•••
Post by whytestockson Dec 06, 2024 6:30pm
48 Views
Post# 36350440

STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against

STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against
BREAKING NEWS: $ASPI STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against ASP Isotopes (ASPI)Philadelphia, Pennsylvania--(Newsfile Corp. - December 6, 2024) - Berger Montague PC advises investors that a securities class action lawsuit has been filed against ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI) on behalf of purchasers of ASP Isotopes securities between Oc...ASPI - STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against ASP Isotopes (ASPI)

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities